Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2004249138 (hide)

Owner Merck & Co., Inc.

Inventors Coleman, Paul J.; Neilson, Lou Anne

Agent Spruson & Ferguson

Pub. Number AU-B-2004249138

PCT Pub. Number WO2004/112699

Priority 60/477,975 12.06.03 US

Filing date 8 June 2004

Wipo publication date 29 December 2004

Acceptance publication date 17 July 2008

International Classifications

A01N 43/58 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 43/52 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 43/60 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 43/76 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A01N 43/78 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/425 (2006.01) - Thiazoles

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/50 (2006.01) - Pyridazines

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/112699 Priority application(s): WO2004/112699

17 July 2008 Application Accepted

  Published as AU-B-2004249138

13 November 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249140-Detection of survivin in the biological fluids of cancer patients

2004249137-Ophthalmic compositions containing a synergistic combination of two polymers